- About us
- Hospitals and centres
- Patients and visitors
- Join our team
- Get involved
- Clinician resources
- Refer your patient
Australia’s first digital hospital, Princess Alexandra Hospital (PAH), is continuing to expand its technological footprint with the introduction of TESA the artificial intelligence (AI) robot into the Oncology clinic as part of a limited trial into how AI can assist healthcare into the future.
The production trial means TESA is stationary within the waiting room in PAH’s busy Oncology Outpatient Department and conducting patient reported experience surveys before they are taken to see their relevant healthcare practitioner.
Enrolled Nurse Advanced Skills for Oncology Outpatients, Mark Ansell, said TESA has been well received by patients.
“TESA has been present in our waiting room for the past two weeks and is already having a positive impact on patients.
“It’s a busy space so, within the first month, we expect around 3500 patients will have interacted with TESA providing us with great feedback on how artificial intelligence can assist us in healthcare moving forward,” he said.
During this initial trial period, TESA’s robotic capabilities are on standby as she works as a survey board to save results.
“Patients are finding TESA very entertaining and she is definitely a point of conversation within the waiting room.
“The majority of patients are supportive and excited about artificial intelligence helping with the delivery of healthcare,” he said.
Currently both the PAH and Royal Brisbane and Women’s Hospital are utilising the EHealth robots with new sights set on Logan Hospital.
If the current trial is successful, the next step is to equip TESA with chemotherapy awareness information, so patients can interact with her about what to expect from their therapy as well as tips for managing side effects.